Drug Shortage Report for ZEVTERA
| Report ID | 131444 |
| Drug Identification Number | 02446685 |
| Brand name | ZEVTERA |
| Common or Proper name | Zevtera |
| Company Name | AVIR PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTOBIPROLE |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 vials |
| ATC code | J01DI |
| ATC description | |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2021-04-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2021-05-06 |
| Shortage status | Resolved |
| Updated date | 2021-05-07 |
| Company comments | Product under allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-05-07 | English | Compare |
| v6 | 2021-05-06 | French | Compare |
| v5 | 2021-05-06 | English | Compare |
| v4 | 2021-05-01 | English | Compare |
| v3 | 2021-01-12 | French | Compare |
| v2 | 2021-01-12 | English | Compare |
| v1 | 2021-01-12 | English | Compare |
Showing 1 to 7 of 7